These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15003905)

  • 21. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
    Markova M; Barker JN; Miller JS; Arora M; Wagner JE; Burns LJ; MacMillan ML; Douek D; DeFor T; Tan Y; Repka T; Blazar BR; Weisdorf DJ
    Bone Marrow Transplant; 2007 Feb; 39(4):193-9. PubMed ID: 17220905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Wang JZ; Gao ZY; Zhang YC; Jiang Q; Shi HX; Lu DP
    Bone Marrow Transplant; 2006 Aug; 38(4):291-7. PubMed ID: 16883312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care.
    Irani JL; Cutler CS; Whang EE; Clancy TE; Russell S; Swanson RS; Ashley SW; Zinner MJ; Raut CP
    Arch Surg; 2008 Nov; 143(11):1041-5; discussion 1046. PubMed ID: 19015460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
    Sobecks RM; Dean R; Rybicki LA; Chan J; Theil KS; Macklis R; Andresen S; Kalaycio M; Pohlman B; Ferraro C; Cherni K; Sweetenham J; Copelan E; Bolwell BJ
    Bone Marrow Transplant; 2008 Dec; 42(11):715-22. PubMed ID: 18711346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
    Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
    Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.
    Jillella AP; Shafer D; Klumpp TR; Emmons RV; Mangan KF
    Am J Hematol; 2007 Jun; 82(6):419-26. PubMed ID: 17211845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB.
    Courtney H
    Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant activated factor VII--"lifesaving or surgeon correcting"?
    Koci J; Dedek T; Havel E; Trlica J
    J Trauma; 2011 Feb; 70(2):523-4; author reply 524-5. PubMed ID: 21307759
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.
    Satwani P; Bessmertny O; Morris E; Cairo MS
    Curr Hematol Rep; 2003 Nov; 2(6):480-90. PubMed ID: 14561392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third biannual report of the Cochrane Haematological Malignancies Group.
    Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
    J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Huang XJ; Jiang Q; Chen H; Xu L; Liu D; Chen Y; Han W; Zhang Y; Liu K; Lu D
    Bone Marrow Transplant; 2005 Aug; 36(4):343-8. PubMed ID: 15968295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).
    Kositchaiwat C; Chuansumrit A
    Thromb Haemost; 2001 Oct; 86(4):1125-6. PubMed ID: 11686340
    [No Abstract]   [Full Text] [Related]  

  • 34. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Uncontrollable bleeding in a patient with head trauma treated with blood component therapy guided by thromboelastography].
    Hansen MK; Jensen MK; Andersen C
    Ugeskr Laeger; 2006 Oct; 168(41):3535-6. PubMed ID: 17059810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alveolar hemorrhage secondary to generalized systemic lupus erithematosus treated with recombinant activated factor VII. Case report and literature review].
    Carrillo-Esper R; Elizondo-Argueta S; Sánchez-Zúñiga Mde J; Carrillo-Córdova JR
    Gac Med Mex; 2007; 143(1):83-6. PubMed ID: 17388100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin.
    Rowley SD; Goldberg SL; Pecora AL; Hsu JS; Brecher BA; Butrin L; Kobbe K; McKiernan P; Preti R
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):784-93. PubMed ID: 15505609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.
    Holler E; Kolb HJ; Greinix H; Perrotin D; Campilho F; Aversa F; Gil L; Cornelissen J; Varanese L; Schacht A; Friese A; Rustige J
    Bone Marrow Transplant; 2009 Mar; 43(6):491-7. PubMed ID: 19079317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
    Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.